Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

[Preparation of dealcholized onetaxotere®, docetaxel injection formulation and its pharmacokinetics in rats].

Onishi K, Tsukiyama I, Katoh M, Ueyama J, Abe F, Saito H, Matsuura K, Hasegawa T, Nadai M.

Gan To Kagaku Ryoho. 2013 Jul;40(7):891-6. Japanese.

PMID:
23863730
[PubMed - indexed for MEDLINE]
2.

De-alcoholization of paclitaxel injection for clinical application.

Tsukiyama I, Takeuchi M, Abe F, Kisi T, Saito H, Obayashi Y, Watanabe K, Wakatsuki A, Miyamoto K, Hasegawa T.

Anticancer Res. 2011 Dec;31(12):4339-46.

PMID:
22199299
[PubMed - indexed for MEDLINE]
3.

Preparation, characterization and pharmacokinetics of N-palmitoyl chitosan anchored docetaxel liposomes.

Liang G, Jia-Bi Z, Fei X, Bin N.

J Pharm Pharmacol. 2007 May;59(5):661-7.

PMID:
17524231
[PubMed - indexed for MEDLINE]
4.

Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.

Lee SW, Yun MH, Jeong SW, In CH, Kim JY, Seo MH, Pai CM, Kim SO.

J Control Release. 2011 Oct 30;155(2):262-71. doi: 10.1016/j.jconrel.2011.06.012. Epub 2011 Jun 24.

PMID:
21704664
[PubMed - indexed for MEDLINE]
5.

Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals.

Li X, Du L, Wang C, Liu Y, Mei X, Jin Y.

Pharmazie. 2011 Jul;66(7):479-83.

PMID:
21812321
[PubMed - indexed for MEDLINE]
6.

[Preparation of docetaxel liposomes and their pharmacokinetics in rabbits].

Huang HB, Liu T, Lin ZC, Zhong JT, Lin PL, Liu JY, Tan YY, Li S, Liao H, Xu YH.

Ai Zheng. 2007 Dec;26(12):1287-91. Chinese.

PMID:
18076788
[PubMed - indexed for MEDLINE]
7.

Determination of docetaxel in rat plasma and its application in the comparative pharmacokinetics of Taxotere and SID530, a novel docetaxel formulation with hydroxypropyl-β-cyclodextrin.

Kim TK, Kim IS, Yoo HH.

Biomed Chromatogr. 2013 Mar;27(3):306-10. doi: 10.1002/bmc.2792. Epub 2012 Jul 27.

PMID:
22837069
[PubMed - indexed for MEDLINE]
8.

High plasma levels and effective lymphatic uptake of docetaxel in an orally available nanotransporter formulation.

Nassar T, Attili-Qadri S, Harush-Frenkel O, Farber S, Lecht S, Lazarovici P, Benita S.

Cancer Res. 2011 Apr 15;71(8):3018-28. doi: 10.1158/0008-5472.CAN-10-3118. Epub 2011 Mar 1.

PMID:
21363913
[PubMed - indexed for MEDLINE]
Free Article
9.

Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier.

Zhao X, Zhao Y, Geng L, Li X, Wang X, Liu Z, Wang D, Bi K, Chen X.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 1;879(31):3721-7. doi: 10.1016/j.jchromb.2011.10.015. Epub 2011 Oct 18.

PMID:
22035980
[PubMed - indexed for MEDLINE]
10.

[Comparative examination of preparation time in docetaxel hydrate formulation].

Arii D, Ikeno Y, Narita K, Murooka K, Nojima M, Kidokoro A.

Gan To Kagaku Ryoho. 2012 Dec;39(13):2533-6. Japanese.

PMID:
23235174
[PubMed - indexed for MEDLINE]
11.

A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution.

Ma M, Hao Y, Liu N, Yin Z, Wang L, Liang X, Zhang X.

Int J Nanomedicine. 2012;7:3389-98. doi: 10.2147/IJN.S29827. Epub 2012 Jul 4.

PMID:
22848167
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Effects of experimental hyperlipidaemia on the pharmacokinetics of docetaxel in rats.

Lee JH, Oh JH, Lee YJ.

Xenobiotica. 2011 Sep;41(9):797-804. doi: 10.3109/00498254.2011.580019. Epub 2011 May 11.

PMID:
21561320
[PubMed - indexed for MEDLINE]
13.

Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation.

Hu K, Cao S, Hu F, Feng J.

Int J Nanomedicine. 2012;7:3537-45. doi: 10.2147/IJN.S32880. Epub 2012 Jul 9.

PMID:
22848177
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Effects of tesmilifene, a substrate of CYP3A and an inhibitor of P-glycoprotein, on the pharmacokinetics of intravenous and oral docetaxel in rats.

Choi YH, Suh JH, Lee JH, Cho IH, Lee MG.

J Pharm Pharmacol. 2010 Aug;62(8):1084-8. doi: 10.1111/j.2042-7158.2010.01129.x.

PMID:
20663044
[PubMed - indexed for MEDLINE]
15.

Pharmacokinetic advantage of intraperitoneal injection of docetaxel in the treatment for peritoneal dissemination of cancer in mice.

Shimada T, Nomura M, Yokogawa K, Endo Y, Sasaki T, Miyamoto K, Yonemura Y.

J Pharm Pharmacol. 2005 Feb;57(2):177-81.

PMID:
15720780
[PubMed - indexed for MEDLINE]
16.

Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers.

Li X, Wang D, Zhang J, Pan W.

J Pharm Pharmacol. 2009 Nov;61(11):1485-92. doi: 10.1211/jpp/61.11.0007.

PMID:
19903373
[PubMed - indexed for MEDLINE]
17.

In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.

Li X, Tian X, Zhang J, Zhao X, Chen X, Jiang Y, Wang D, Pan W.

Int J Nanomedicine. 2011;6:1167-84. doi: 10.2147/IJN.S21445. Epub 2011 Jun 9.

PMID:
21852896
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.

Qu G, Wu X, Yin L, Zhang C.

Biomed Pharmacother. 2012 Feb;66(1):46-51. doi: 10.1016/j.biopha.2011.09.010. Epub 2011 Dec 30.

PMID:
22264883
[PubMed - indexed for MEDLINE]
19.

Advances in the formulations of non-injection administration of docetaxel.

Zhang H, Dou J, Zhai Y, Liu A, Zhai G.

J Drug Target. 2014 Feb;22(2):87-94. doi: 10.3109/1061186X.2013.839686. Epub 2013 Oct 7. Review.

PMID:
24098909
[PubMed - indexed for MEDLINE]
20.

Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel.

Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L.

J Control Release. 2003 Sep 4;91(3):417-29.

PMID:
12932719
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk